Washington’s China Biotech Crackdown Sparks Cold War Concerns for India

Washington has intensified its crackdown on Chinese biotech firms. The move is framed as part of a broader strategic competition. Analysts argue the policy shift creates a new biotech cold war. India is identified as a key regional player affected by the tension. The Sentinel highlights potential impacts on Indian research collaborations. The crackdown may force Indian firms to reassess supply chains. Policymakers in India are urged to consider security and innovation balance. Observers will monitor how the rivalry shapes future biotech partnerships.